Discover
NRXS
NeurAxis, Inc.
7.08
300 x undefined
100 x undefined
bid
ask
-
0.23
3.15%
200 @ 04:00 PM
6.90 -0.18 (2.54%)
| Ytd | 55.95% | |
| 1y | 197.48% |
6.96
day range
7.25
2.20
52 week range
9.33
| Open | 7.20 | Prev Close | 7.31 | Low | 6.96 | High | 7.25 | Mkt Cap | 87.68M |
| Vol | 88.02K | Avg Vol | 150.33K | EPS | -0.80 | P/E | N/A | Forward P/E | -23.30 |
| Beta | N/A | Short Ratio | 1.54 | Inst. Own | 1.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 7.43 | 200-d Avg | 5.11 | 1yr Est | 7.50 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | 0 | -0.25 | N/A | N/A |
| 2024-08-09 | 2024-06 | 0 | -0.42 | N/A | N/A |
| 2024-05-20 | 2024-03 | 0 | -0.32 | N/A | N/A |
| 2023-11-20 | 2023-09 | 0 | -1.06 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-06-27 | FERGE KRISTIN A | Director | 1.18K | Stock Award(Grant) |
| 2024-02-19 | HANNASCH BRIAN | Beneficial Owner of more than 10% of a Class of Security | 757.90K | Stock Award(Grant) |
| 2024-06-27 | KEYSER JANE ELIZABETH | Director | 11.58K | Stock Award(Grant) |
| 2023-08-10 | MASIMO CORP. | Beneficial Owner of more than 10% of a Class of Security | 531.55K | Conversion of Exercise of derivative security |
| 2024-06-27 | WATKINS BRADLEY MITCHELL | Director | 11.58K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Bank of Montreal /CAN/ | 149.02K | 347.21K | 2.13% |
| 2024-09-29 | Vanguard Group Inc | 27.98K | 65.19K | 0.40% |
| 2024-09-29 | Stifel Financial Corporation | 25.71K | 59.90K | 0.37% |
| 2024-09-29 | Geode Capital Management, LLC | 22.70K | 52.90K | 0.33% |
| 2024-09-29 | Royal Bank of Canada | 15.10K | 35.19K | 0.22% |
| 2024-09-29 | Parsons Capital Management, Inc. | 13.00K | 30.29K | 0.19% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 17.75K | 41.35K | 0.25% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 17.76K | 41.37K | 0.25% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 10.24K | 23.85K | 0.15% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 4.26K | 9.93K | 0.06% |